--- title: Should You Mix and Match Omicron Booster? description: With new Omicron-specific boosters available from Pfizer-BioNTech and Moderna, should you mix and match brands? Here's what to know. canonical: https://time.com/6211330/omicron-booster-mix-match-moderna-pfizer/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2022-09-07T18:28:48.000Z article:modified_time: 2026-10-14T09:39:20.721Z article:section: Health og:title: Should You Mix and Match Omicron Boosters? Here's What to Know og:description: There are no human data yet on the new Omicron booster, but past research hints at an answer og:url: https://time.com/6211330/omicron-booster-mix-match-moderna-pfizer/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt64799f5e48b9da47/698a353822fb8539d3e2dd6e/covid-vaccine-syringes-moderna.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 2400 og:image:height: 1350 og:image:alt: covid-19-vaccine og:type: article twitter:card: summary_large_image twitter:title: Should You Mix and Match Omicron Boosters? Here's What to Know twitter:description: There are no human data yet on the new Omicron booster, but past research hints at an answer twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt64799f5e48b9da47/698a353822fb8539d3e2dd6e/covid-vaccine-syringes-moderna.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # Should You Mix and Match Omicron Boosters? Here's What to Know > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=36b886c6-dd3d-4750-bb82-81c6894e0aac&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=36b886c6-dd3d-4750-bb82-81c6894e0aac&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=36b886c6-dd3d-4750-bb82-81c6894e0aac&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=36b886c6-dd3d-4750-bb82-81c6894e0aac&cr=time-nl-network-2026q3-v1) ## Video: US Rolls Out Updated COVID-19 Vaccine Boosters [Watch (HLS stream): US Rolls Out Updated COVID-19 Vaccine Boosters](https://cdn.jwplayer.com/manifests/kgp116XU.m3u8) (2:51)  _Published 2022-09-07. The FDA and CDC both approved the updated bivalent COVID-19 vaccines last week. The promise of the mRNA vaccine technology platform was always that we could update them quickly. We may finally have achieved an advantage over SARS-COV-2 as the updated vaccine recipe matches the current dominant circulating BA.5 strain (and slow growing BA.4.6 strain) without another more transmissible variant of concern yet on the horizon._  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Sep 7, 2022 6:28 PM UTC The FDA and CDC both approved the updated bivalent COVID-19 vaccines last week. The promise of the mRNA vaccine technology platform was always that we could update them quickly. We may finally have achieved an advantage over SARS-COV-2 as the updated vaccine recipe matches the current dominant circulating BA.5 strain (and slow growing BA.4.6 strain) without another more transmissible variant of concern yet on the horizon.  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Sep 7, 2022 6:28 PM UTC Health officials say it’s time for most Americans to get another booster dose—this time, with a new [Omicron-specific shot](https://time.com/6210478/cdc-fall-booster-shots-omicron/) made by either Pfizer-BioNTech (for people 12 and older) or Moderna (for adults 18 and older). But should you stick with the vaccine brand you’ve been using, or can you mix and match? Here’s what to know. ## Mixing and matching booster doses is likely fine Several COVID-19 vaccines have become available in the U.S. since the first shots were authorized at the end of 2020\. Currently, two primary-series COVID-19 vaccines (made by Pfizer-BioNTech and Moderna) are approved by the U.S. Food and Drug Administration (FDA), and two (made by Johnson&Johnson-Janssen and Novavax) are authorized for emergency use. Shots from Pfizer-BioNTech and Moderna are approved as booster doses, and J&J’s booster is authorized for those who received that brand for their one-dose primary shot, or for those who cannot safely receive the other boosters because of the risk of side effects. The U.S. Centers for Disease Control and Prevention (CDC) recommends that people not mix the two primary series doses of the mRNA vaccine—so if you’ve been vaccinated with Pfizer-BioNTech for your first dose, for example, your second dose should also be from Pfizer-BioNTech; the same goes for Moderna. But the abundance of options means you may have already received a booster dose from a different manufacturer, and that’s just fine. [Studies](https://time.com/6107027/covid-vaccine-mix-and-match/) have shown that people who received mRNA booster doses of the original vaccine made by a different manufacturer than that of the primary series generated similar virus-fighting antibodies against SARS-CoV-2, compared to people who got the same brand of primary and booster shot. That was the case with the original vaccines and boosters. But [human studies of the new Omicron boosters have not been completed](https://time.com/6208623/omicron-boosters-animals-clinical-trials/) yet—they will be launched in September—so there are no data yet on what happens when people who have been vaccinated with one company’s shots then get an Omicron booster made by a different company. It’s also not clear what happens, for instance, if someone who was vaccinated with Moderna’s shot, then boosted with Pfizer-BioNTech’s, now gets a Pfizer-BioNTech or Moderna Omicron booster. But based on previous studies of mixing and matching, health officials are relatively confident that the booster doses are interchangeable, and the CDC [says](https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html?s%5Fcid=11706:covid%20vaccine%20booster:sem.ga:p:RG:GM:gen:PTN:FY22) people over 18 “may get a different product for a booster than they got for their primary series, as long as it’s Pfizer-BioNTech or Moderna.” One thing to keep in mind, however, is that all along, Moderna’s vaccine doses have been slightly higher than those from Pfizer-BioNTech. The same is true of Moderna’s new Omicron booster**.** A higher dose means that people getting Moderna’s Omicron booster may experience slightly higher rates of side effects, such as swelling, arm soreness, fever, and fatigue compared to people who get Pfizer-BioNTech’s. But it may potentially come with an advantage, if the experience with the original booster shots is any guide. Earlier [studies](https://time.com/6107027/covid-vaccine-mix-and-match/) involving people who received the original Moderna booster suggested that they generated higher levels of virus-fighting antibodies compared to people who received a Pfizer-BioNTech booster. ## Can you mix and match booster doses for kids? It depends on how old your child is and which vaccine they received as their primary series. Children ages 12 to 17 who were vaccinated with either Moderna’s or Pfizer-BioNTech’s shots as their primary series can get boosted with Pfizer-BioNTech’s new Omicron booster. Neither Omicron booster is authorized yet for children under 12—so those children will still receive a booster of the original vaccine (if they’re eligible to get boosted). If your child was vaccinated with Moderna as a primary series, Moderna booster doses of any kind—original or Omicron-specific—have not been authorized for children six months to 11 years old yet. Children in this age group who were vaccinated with Moderna are not recommended to get a booster dose at this time. Children five to 11 years old who were vaccinated with Pfizer-BioNTech can only get an original vaccine booster, not the bivalent Omicron booster, made by Pfizer-BioNTech. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6211330/omicron-booster-mix-match-moderna-pfizer/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6211330/omicron-booster-mix-match-moderna-pfizer/"},"headline":"Should You Mix and Match Omicron Boosters? Here's What to Know","datePublished":"2022-09-07T18:28:48.000Z","dateModified":"2026-10-14T09:39:20.721Z","description":"There are no human data yet on the new Omicron booster, but past research hints at an answer.","url":"https://time.com/6211330/omicron-booster-mix-match-moderna-pfizer/","keywords":["COVID-19","healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt64799f5e48b9da47/698a353822fb8539d3e2dd6e/covid-vaccine-syringes-moderna.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt64799f5e48b9da47/698a353822fb8539d3e2dd6e/covid-vaccine-syringes-moderna.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"covid-19-vaccine","caption":"covid-19-vaccine","creditText":"Donato Fasano—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6211330/omicron-booster-mix-match-moderna-pfizer/","name":"Should You Mix and Match Omicron Boosters? Here's What to Know"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"US Rolls Out Updated COVID-19 Vaccine Boosters","description":"The FDA and CDC both approved the updated bivalent COVID-19 vaccines last week. The promise of the mRNA vaccine technology platform was always that we could update them quickly. We may finally have achieved an advantage over SARS-COV-2 as the updated vaccine recipe matches the current dominant circulating BA.5 strain (and slow growing BA.4.6 strain) without another more transmissible variant of concern yet on the horizon.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/kgp116XU/poster.jpg?width=720","uploadDate":"2022-09-07T16:22:52.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/kgp116XU.m3u8","embedUrl":"https://time.com/6211330/omicron-booster-mix-match-moderna-pfizer/","duration":"PT2M51S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/6211330/omicron-booster-mix-match-moderna-pfizer/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```